RE:RE:More newsbcsc - (4/27/2016 9:05:42 AM) RE:More news It is great to see the technological successes but the market is waiting to see if they can translate them into commercial successes.
This is exactly right. The broader 'market' will not take notice until the financials show a profit. And significant profit at that. Pascali et al. are demonstrating some great ingenuity and innovative application of their plasma expertise, so the potential is there. But for them to take the next step they have to forge a visible commercial partnership and some recurring revenues. At the moment pretty much everything is a pilot or one-off with unnamed partners/customers.
They're at a normal (but critical) stage of corporate development. They have some good tech and some interesting patent claims. They have managed themselves fairly well given their size and presumed overhead. They have laid the groundwork. Now they have to actually penetrate commercial markets. Drosrite looks it might, but the other apps are still long on potential and short on buyers.
This was (and continues to be) a long speculative buy for me. Profitability still looks a ways off, so not sure I'll accumulate at these levels, but any drops under .25 will be tempting. New of recurring revenues could easily push it back above .40 or .50.
The caution I have now is that - although there has been a flurry of news - I have not seen any financial statements posted to SEDAR since November 2015 (for Q3?). Meaning that Q4/Year End(?) is past due and should have been posted at end of March (90 days after end of year). Not sure if this suggests audit issues, but something should be forthcoming. Especially considering they have the time to make all these forward looking pronouncements.